Diagnosis of myocarditis as one of the actual problems in cardiology
Article Sidebar
Main Article Content
Abstract
Nowadays the diagnosis and prognosis of myocarditis is one of the most pressing, complex and incompletely solved problems in modern cardiology, that exist due to the large polymorphism of clinical manifestations of this disease and because of the lack of specific symptoms and diagnostic criteria. In most cases, the occurrence of heart failure, pain, heart rhythm and conduction disorders or other clinical manifestations are observed on the 2nd week after the onset of infectious disease, but inflammatory heart disease may not have a clear connection with the infection. Among the main methods used to diagnose myocarditis in clinical practice are electrocardiography (ECG), Holter monitoring (HM) ECG, echocardiography (echocardiography) and speckle-tracking (ST) echocardiography, cardiac magnetic resonance (CMR) imaging and endomyocardial biopsy. ECG and HMECG are highly informative methods for detection, prediction and dynamic monitoring of frequent complications of myocarditis – arrhythmias and conduction disorders. Two-dimensional echocardiography is a mandatory technique for assessing myocardial contractility that allows to assess the size of the heart chambers, systolic and diastolic function, global and regional contractility, the presence of thrombosis in the cavities, pericardial effusion and, most importantly. In recent years, there has been increasing data on the use of CT echocardiography for the diagnosis of myocarditis, based on the assessment of myocardial deformation and its rate in the longitudinal, radial and circular directions. Contrast-enhanced magnetic resonance imaging of the heart is non-invasive and one of the most informative methods for detecting signs of inflammatory myocardial damage. CMR allows to visualize the anatomy, study the structure and characterize the tissue of the heart, determine the functional features of the atria and ventricles. However, the gold standard for verifying the diagnosis of myocarditis to this day remains endomyocardial biopsy. Laboratory methods of diagnosis are additional researches, that in a complex with instrumental methods allow to estimate changes of myocardial inflammatory process at long supervision.
Article Details
Keywords:
References
Гавриленко Т.І., Чернюк С.В., Підгайна О.А. та ін. Визначення діагностичної і прогностичної ролі імунологічних біомаркерів у пацієнтів з міокардитом // Світ медицини та біології.– 2019.– № 2 (68).– C. 34–39. doi: https://doi.org/10.26724/2079-8334-2019-2-68-34-39.
Коваленко В.М., Несукай О.Г., Чернюк С.В. та ін. Міокардит: сучасний стан проблеми і пошук нових підходів до діагностики // Укр. кардіол. журн.– 2016.– № 6.– С. 15–24.
Коваленко В.Н., Несукай Е.Г., Чернюк С.В. Миокардит: современный взгляд на этиологию и патогенез заболевания // Укр. кардіол. журн.– 2012.– № 2.– С. 84–92.
Коваленко В.М., Несукай О.Г., Чернюк С.В., Кириченко Р.М. Прогнозування перебігу міокардиту на основі комплексного аналізу імунного статусу та структурно-функціонального стану серця // Укр. кардіол. журн.– 2017.– № 5.– С. 68–74.
Рябенко Д.В. Современное состояние проблемы миокардитов // Серцева недостатність та коморбідні стани.– 2018.– № 1.– С. 36–42.
Ammirati E., Veronese G., Bottiroli M. et al. Update on acute myocarditis // Trends in Cardiovascular Medicine.– 2020. doi: https://doi.org/10.1016/j.tcm.2020.05.008.
Arnold J.R., McCann G.P. Cardiovascular Magnetic Resonance: Applications and Practical Considerations for the General Cardiologist // Heart.– 2020.– Vol. 106 (3).– P. 174–181. doi: https://doi.org/10.1136/heartjnl-2019-314856.
Baldeviano G.C., Barin J.G., Talor M.V. et al. Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy // Circulation Research.– 2010.– P. 1646–1655. doi: https://doi.org/10.1161/CIRCRESAHA.109.213157.
Bettencourt N. Cardiac magnetic resonance in myocarditis – do we need more tools? // Rev. Port Cardiol.– 2019.– Vol. 38 (11).– P. 777–778. doi: https://doi.org/10.1016/j.repc.2020.01.002.
Biestroek P.S., Beek A.M., Germans T. et al. Diagnosis of myocarditis: current state and future perspectives // Int. J. Cardiol. – 2015.– Vol. 191.– P. 211–219. doi: https://doi.org/10.1016/j.ijcard.2015.05.008.
Bracamonte-Baran W., Čiháková D. Cardiac Autoimmunity: Myocarditis // Adv. Exp. Med. Biol.– 2017.– Vol. 1003.– P. 187–221. doi: https://doi.org/10.1007/978-3-319-57613-8_10.
Caforio A.L., Malipiero G., Marcolongo R., Iliceto S. Myocarditis: a clinical overview // Curr. Cardiol. Rep.– 2017.– Vol. 19 (7).– P. 63. doi: https://doi.org/10.1007/s11886-017-0870-x.
Caforio A.L., Pankuweit S., Arbustini E. et al. Current state of knowledge on aetiology, diagnosis, management and therapy of myocarditis: a position statement of the ESC Working group on myocardial and pericardial diseases // Eur. Heart J.– 2013.– Vol. 34 (33).– P. 2636–2648. doi: https://doi.org/10.1093/eurheartj/eht210.
Cecco C.N.D., Monti C.B. Use of Early T1 Mapping for MRI in Acute Myocarditis // Radiology.– 2020.– Vol. 295 (2).– P. 326–327. doi: https://doi.org/10.1148/radiol.2020200171.
Chen W., Jeudy J. Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR? // Curr. Cardiol Rep.– 2019.– Vol. 21 (8).– P. 76. doi:https://doi.org/10.1007/s11886-019-1158-0.
Ebert M., Richter S., Dinov B. et al. Evaluation and management of ventricular tachycardia in patients with dilated cardiomyopathy // Heart Rhythm.– 2019.– Vol. 16 (4).– P. 624–631. doi: https://doi.org/10.1016/j.hrthm.2018.10.028.
Eichhorn C., Bière L., Schnell F. et al. Myocarditis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncertainties // JACC Cardiovasc. Imaging.– 2019.– Vol. 13.– P. 494–507. doi: https://doi.org/10.1016/j.jcmg.2019.01.039.
Fairweather D., Cooper L.T., Blauwet L.A. Sex and gender differences in myocarditis and dilated cardiomyopathy // Curr. Probl. Cardiol.– 2013.– Vol. 38 (1).– P. 7–46. doi: https://doi.org/10.1016/j.cpcardiol.2012.07.003.
Ferreira V.M., Piechnik S.K., Dall’Armellina E. et al. T1 Mapping for the diagnosis of acute myocarditis using CMR: Comparison to T2-Weighted and late gadolinium enhanced imaging // JACC: Cardiovascular Imaging.– 2013.– Vol. 6 (10).– P. 1048–1058. doi: https://doi.org/10.1016/j.jcmg.2013.03.008.
Ferreira V.M., Schulz-Menger J., Holmvang G. et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: Expert recommendations. // J. Am. Coll. Cardiol.– 2018.– Vol. 72 (24).– P. 3158–3176. doi: https://doi.org/10.1016/j.jacc.2018.09.072
Friedrich M.G., Sechtem U., Schulz-Menger J. et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper // J. Am. Coll. Cardiol.– 2009.– Vol. 53 (17).– P. 1475–1487. doi: 10.1016/j.jacc.2009.02.007.
Fung G., Luo H., Qiu Y., Yang D., McManus B. Myocarditis // Circ. Res. 2016.– Vol. 118 (3).– P. 496–514. doi: https://doi.org/10.1161/CIRCRESAHA.115.306573.
Goitein O., Matetzky S., Beinart R. et al. Acute myocarditis noninvasive evaluation with cardiac MRI and transthoracic echocardiography // Am. J. Roentgenol.– 2009.– Vol. 192.– P. 254–258. doi: https://doi.org/10.2214/AJR.08.1281.
Gonzalez J. A., Kramer C.M. Role of imaging techniques for diagnosis, prognosis and management of heart failure patients: cardiac magnetic resonance // Curr. Heart Fail.– 2015.– Vol. 12 (4).– P. 276–283. doi: https://doi.org/10.1007/s11897-015-0261-9.
Gräni C., Eichhorn C., Bière L. et al. Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis // J. Am. Coll. Cardiol.– 2017.– Vol. 70 (16).– P. 1964–1976. doi: https://doi.org/10.1016/j.jacc.2017.08.050.
Guglin M., Nallamshetty L. Myocarditis: diagnosis and treatment // Curr. Treat Options Cardiovasc. Med.– 2012.– Vol. 14 (6).– P. 637–651. doi: https://doi.org/10.1007/s11936-012-0204-7.
He J., Yang L. Value of three-dimensional speckle-tracking imaging in detecting left ventricular systolic function in patients with dilated cardiomyopathy // Echocardiography.– 2019.– Vol. 36 (8).– P. 1492–1495. doi: https://doi.org/10.1111/echo.14427.
Heidecker B., Kittleson M.M., Kasper K.E. et al. Transcriptomic biomarkers for the accurate diagnosis of myocarditis // Circulation.– 2011.– Vol. 123 (11).– P. 1174–1184. doi: https://doi.org/10.1161/CIRCULATIONAHA.110.002857.
Heymans S., Eriksson U., Lehtonen J., Cooper T.L. The quest for new approaches in myocarditis and inflammatory cardiomyopathy // J. Am. Coll. Cardiol.– 2016.– Vol. 68 (21).– P. 2348–2364. doi: https://doi.org/10.1016/j.jacc.2016.09.937.
Huber S.A. Viral myocarditis and dilated cardiomyopathy: etiology and pathogenesis // Curr. Pharm. Des.– 2016.– Vol. 22 (4).– P. 408–426. doi: https://doi.org/10.2174/1381612822666151222160500.
Hundley G.W., Bluemke A.D., Finn P.J. et al. ACCF/ACR/AHA/ NASCI/SCMR 2010 Expert consensus document on cardiovascular magnetic resonance: a report of the American college of cardiology foundation task force on the expert consensus documents // Circulation.– 2010.– Vol. 55 (23).– P. 2614–2662. doi: https://doi.org/10.1016/j.jacc.2009.11.011.
Imanaka-Yoshida K. Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy // Pathology International.– 2020.– Vol. 1.– P. 1–11. doi: https://doi.org/10.1111/pin.12868.
Japp G.A., Gulati A., Cook A.S. et al. The Diagnosis and Evaluation of Dilated Cardiomyopathy // J. Am. Coll. Cardiol.– 2016.– Vol. 67 (25).– P. 2996–3010. doi: https://doi.org/10.1016/j.jacc.2016.03.590
Kadkhodayan A., Chareonthaitawee P., Raman V.S., Cooper T.L. Imaging of inflammation in unexplained cardiomyopathy // JACC: Cardiovascular Imaging.– 2016.– Vol. 9 (5).– P. 603–617. doi: https://doi.org/10.1016/j.jcmg.2016.01.010.
Kasner M., Sinning D., Escher F. et al. The utility of speckle tracking imaging in the diagnostic of acute myocarditis, as proven by endomyocardial biopsy // Int. J. Cardiol.– 2013.– Vol. 168 (3).– P. 3023–3024. doi: https://doi.org/10.1016/j.ijcard.2013.04.016.
Kim M.J., Hong G.R., Ha J.W., Shim C.Y. Acute Localized Myocarditis: Role of Speckle Tracking Echocardiography // Korean Circ. J.– 2020.– Vol. 50 (7).– P. 638–640. doi: https://doi.org/10.4070/kcj.2019.0378.
Kindermann I., Barth C., Mahfoud F. et al. Update on myocarditis // J. Am. Coll. Cardiol.– 2012.– Vol. 59 (9).– Р. 779–792. doi:https://doi.org/10.1016/j.jacc.2011.09.074.
Krejci J., Mlejnek D., Sochorova D., Nemec P. Inflammatory cardiomyopathy: a current view on pathophysiology, diagnosis and treatment // BioMed Research International.– 2016.– P. 1–11. doi: https://doi.org/10.1155/2016/4087632.
Kuruvilla S., Adenaw N., Katwal A.B. et al. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis // Circ. Cardiovasc. Imaging.– 2014.– Vol. 7 (2).– P. 250–258. doi: https://doi.org/10.1161/CIRCIMAGING.113.001144.
Lang M.R., Badano P.L., Mor-Avi V. et al. Recommendations for cardiac chamber quantification in adults: an update from the American Society of echocardiography and European Asssociation of cardiovascular imaging // Eur. Heart J. Cardiovasc. Imaging.– 2015.– Vol. 16 (3).– P. 233–271. doi: https://doi.org/10.1093/ehjci/jev014.
Leone O., Pieroni M., Rapezzi C., Olivotto I. The spectrum of myocarditis: from pathology to the clinics // Virchows Arch.– 2019.– Vol. 475 (3).– P. 279–301. doi:https://doi.org/10.1007/s00428-019-02615-8.
Lu M., Samblanet K., Roberts C. Myocarditis: a heart on fire // Curr. Sports Med. Rep.– 2020.– Vol. 19 (3).– P. 110–112. doi: https://doi.org/10.1249/JSR.0000000000000698.
Luetkens A.J., Doerner J., Thomas K.D. et al. Acute Myocarditis: Multiparametric Cardiac MR Imaging // Radiology.– 2014.– Vol. 273 (2).– P. 383–392. doi: https://doi.org/10.1148/radiol.14132540.
Lurz P., Eitel I., Adam J. et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis // JACC Cardiovasc Imaging.– 2012.– Vol. 5 (5).– P. 513–524. doi: https://doi.org/10.1016/j.jcmg.2011.11.022.
Luyt C.E., Hékimian G., Ginsberg F. What’s new in myocarditis? // Intensive Care Med.– 2016.– Vol. 42 (6).– P. 1055–1057. doi: https://doi.org/10.1007/s00134-015-4017-5.
Maisch B., Ristic A.D., Pankuweit S. Inflammatory cardiomyopathy and myocarditis // Herz.– 2017.– Vol. 42 (4).– P. 425–438. doi: https://doi.org/10.1007/s00059-017-4569-y.
Marchant J.D., Boyd H.J., Lin C.D. et al. Inflammation in Myocardial Disease // Circ. Res.– 2012.– Vol. 110 (1).– P. 126–144. doi:https://doi.org/10.1161/CIRCRESAHA.111.243170.
Mewton N., Dernis A., Bresson D. et al. Myocardial biomarkers and delayed enhancened cardiac magnetic resonance relationship in clinically suspected myocarditis and insight on clinical outcome // J. Cardiovasc. Med.– 2015.– Vol. 16 (10).– P. 696–703. doi: https://doi.org/10.2459/JCM.0000000000000024.
Nensa F., Kloth J., Tezgah E. et al. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI // J. Nucl. Cardiol.– 2016.– Vol. 25.– P. 616–624. doi: https://doi.org/10.1007/s12350-016-0616-y.
Palmisano A., Benedetti G., Faletti R. et al. Early T1 myocardial MRI mapping: value in detecting myocardial hyperemia in acute myocarditis // Radiology.– 2020.– Vol. 295 (2).– Р. 316–325. doi: https://doi.org/10.1148/radiol.2020191623.
Pinto Y.M., Elliott P.M., Arbustini E et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases // Eur. Heart J.– 2016.– Vol. 37 (23).– P. 1850–1858. doi: https://doi.org/10.1093/eurheartj/ehv727.
Sachedeva S., Song X., Dham N. et al. Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis // Am. J. Cardiol.– 2015.– Vol. 115 (4).– P. 499–504. doi: https://doi.org/10.1016/j.amjcard.2014.11.029.
Schultheiss H.P., Fairweather D., Caforio A.L.P. et al. Dilated cardiomyopathy // Nat. Rev. Dis. Primers.– 2019.– Vol. 5 (1).– P. 32. doi: https://doi.org/10.1038/s41572-019-0084-1.
Seferovic P.M., Polovina M., Bauersachs J. et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology // Eur. J. Heart Failure.– 2019.– Vol. 21.– P. 553–576. doi: https://doi.org/10.1002/ejhf.1461.
Shah Z., Mohammed M., Vuddanda V. et al. National Trends, Gender, Management, and Outcomes of Patients Hospitalized for Myocarditis // Am. J. Cardiol.– 2019.– Vol. 124 (1).– P. 131–136. doi: 10.1016/j.amjcard.2019.03.036.
Sinagra G.F., Anzini M., Pereira N.L. et al. Myocarditis in clinical practice // Mayo Clin. Proc.– 2016.– Vol. 91 (9).– P. 1256–1266. doi: https://doi.org/10.1016/j.mayocp.2016.05.013.
Taylor A.J., Salerno M., Dharmakumar R., Jerosch-Herold M. T1 mapping: basic techniques and clinical application // JACC: Cardiovascular Imaging.– 2016.– Vol. 9 (1).– P. 67–81. doi: https://doi.org/10.1016/j.jcmg.2015.11.005.
Treibel T.A., Fridman Y., Bering P. et al. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1 // JACC: Cardiovascular Imaging.– 2020.– Vol. 13 (1).– P. 44–54. doi: https://doi.org/10.1016/j.jcmg.2019.03.017.
Van Linthout S., Tschöpe C. Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy // Curr. Opin. Cardiol.– 2018.– Vol. 33 (3).– P. 325–333. doi: https://doi.org/10.1097/HCO.0000000000000515.
Woudstra L., Juffermans L.J.M., van Rossum A.C. et al. Infectious myocarditis: the role of the cardiac vasculature // Heart Fail. Rev.– 2018.– Vol. 23 (4).– P. 583–595. doi: https://doi.org/10.1007/s10741-018-9688-x.
Yusuf S.W., Durand J.B., Banchs J. Endocarditis and Myocarditis: A Brief Review // Expert Rev. Cardiovasc. Ther.– 2012.– Vol. 10 (9).– P. 1153–1164. doi: https://doi.org/10.1586/erc.12.107.
Zhao L., Fu Z. Roles of host immunity in viral myocarditis and dilated Cardiomyopathy // J. Immunol. Res.– 2018.– Vol. 2018.– Р. 5301548. doi: https://doi.org/10.1155/2018/5301548.